SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-060293
Filing Date
2008-09-25
Accepted
2008-09-25 08:30:41
Documents
5
Period of Report
2008-09-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-24243_18k.htm 8-K 40401
2 EX-10.1 a08-24243_1ex10d1.htm EX-10.1 48423
3 EX-10.2 a08-24243_1ex10d2.htm EX-10.2 236479
4 EX-99.1 a08-24243_1ex99d1.htm EX-99.1 6653
5 GRAPHIC g242431mmi001.jpg GRAPHIC 2524
  Complete submission text file 0001104659-08-060293.txt   337267
Mailing Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063
Business Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063 650-454-1000
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 081087657
SIC: 2836 Biological Products, (No Diagnostic Substances)